Abstract：Objective: To explore the selection of vascular access and the use of internal fistula in patients with end-stage renal disease. Methods: 80 ESRD patients enrolled for hemodialysis in the blood purification center of the department of nephrology of our hospital from June 2017 to January 2019 were selected as the study objects. According to the establishment of vascular access, the patients were divided into arteriovenous fistula and central venous catheter group.The clinical data of the two groups were compared and the influencing factors of vascular access selection in patients with initial hemodialysis were analyzed. Results: Of the 80 ESRD patients, 12 (15%) established AVF and 68 (85%) established CVC. Univariate analysis showed that gender, age, BMI, glomerular filtration rate and ESRD etiology of ESRD patients in the two groups had no statistically significant difference in vascular access selection (P>0.05). After 6 months of follow-up, the overall incidence of complications was 25% in the AVF group and 57.35% in the CVC group, indicating a statistically significant difference between the two groups (χ2=4.281, P<0.05). In addition, within 6 months of 80 patients undergoing maintenance dialysis, 1 patient in the AVF group was converted to kidney transplantation, and 11 patients were still treated with AVF, with a treatment conversion rate of 8.33% (1/12). In the CVC group, 48 patients were converted to AVF, 5 to peritoneal dialysis, 2 to kidney transplantation, and only 13 remained CVC, with a treatment conversion rate of 80.88% (55/68). Multivariate Logistic regression analysis showed that education level, regional distribution, residence location, and the time from the recommended fistula to the start of dialysis were all relevant influencing factors for the use of AVF(B=-2.954, 3.024, -2.479, -2.259, P均<0.05). Conclusion: Most HD patients were treated with deep vein catheter for the first time, and the use rate of AVF was very low. In addition, there are many factors influencing the use rate of AVF during the first dialysis, including education level, regional distribution, registered permanent residence location, and the recommended time from fistulation to the beginning of dialysis.
赵艳红, 李红梅, 杨崇猛, 童宗武, 孙阳. 终末期肾脏病患者初次HD血管通路选择及内瘘使用相关因素分析[J]. 河北医学, 2020, 26(4): 635-639.
ZHAO Yanhong, LI Hongmei, YANG Chongmeng, et al. Analysis of Factors Related to Vascular Access Selection and Internal Fistula Use in Patients with End-stage Renal Disease. HeBei Med, 2020, 26(4): 635-639.
[1] Bahall M . Use of complementary and alternative medicine by patients with end-stage renal disease on haemodialysis in Trinidad: A descriptive study[J]. Bmc Complementary & Alternative Medicine, 2017, 17(1):250. [2] 刘晓辉,单岩,时秋英.血液透析患者动静脉内瘘穿刺疼痛的影响因素[J].郑州大学学报(医学版),2013,48(06):810~813. [3] Vand P W Y, Dulfer R R, Engelsman A F,et al.Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review[J]. Nephrology Dialysis Transplantation, 2017. [4] 桂永丰.新入HD患者血管通路选择情况及影响通路选择的因素[J].航空航天医学杂志,2018,29(2):247~249. [5] 高豆青,单岩,张琳,等.终末期肾脏病患者与主要照顾者疾病不确定感的相关性研究[J].重庆医学,2017,46(8):1145~1148. [6] 宋晓萍,邓湘佐.浅谈临时血管通路在HD患者中的应用[J].中国医药指南,2017,15(34):138~139. [7] 李冰心,周小兵,杨林,等.终末期肾病患者首次HD血管通路应用状况的单中心调查[J].临床肾脏病杂志,2018,18(12):775~777. [8] 任红旗,何群鹏,贾凤玉,等.维持性HD患者血管通路使用情况分析[J].肾脏病与透析肾移植杂志,2017,26(3):235~239. [9] 王捷.HD患者血管通路使用情况及影响因素分析[J].中外医学研究,2018,16(18):166~168. [10] 李洋.HD患者血管通路的评估和监测[J].医药前沿,2017,7(16):149. [11] 危志强,章旭,蔡小琴,等.单中心维持性HD患者血管通路的现状分析[J].临床肾脏病杂志,2019,19(3):211~213.
2020, Vol. 26 
冀公网安备13080202000677号